Odyssey Health (ODYY) Cash & Equivalents Growth (5y) (2019 - 2026)
Odyssey Health (ODYY) Cash & Equivalents Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Odyssey Health | 1.07 Mn | 771,705.04 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -26.39% |
| Jan 31, 2026 | 57.76% |
| Oct 31, 2025 | -38.58% |
| Jul 31, 2025 | -49.06% |
| Apr 30, 2025 | -34.61% |
| Jan 31, 2025 | 21.10% |
| Oct 31, 2024 | -12.04% |
| Jul 31, 2024 | -57.27% |
| Apr 30, 2024 | 188.90% |
| Jan 31, 2024 | 205.05% |
| Oct 31, 2023 | 187.64% |
| Jul 31, 2023 | 148.38% |
| Apr 30, 2023 | -27.46% |
| Jan 31, 2023 | 145.30% |
| Oct 31, 2022 | 34.37% |
| Jul 31, 2022 | 40.13% |
| Apr 30, 2022 | 156.25% |
| Jan 31, 2022 | 74.82% |
| Oct 31, 2021 | 278.06% |
| Jul 31, 2021 | 101.55% |